A surprisingly large proportion of new drug candidates emerging from drug discovery programmes are water insoluble, and therefore poorly bioavailable, leading to abandoned development efforts. These so-called 'brickdust' candidates can now be rescued by formulating them into crystalline nanosuspensions. In the process of overcoming issues involving solubility, additional pharmacokinetic benefits of the drugs so formulated have come to be appreciated. As such, insolubility issues of the past have provoked a paradigm change, which now offers novel solutions for innovative drugs of the future.
机构:
Yuan Ze Univ, Dept Chem Engn & Mat Sci, Tao Yuan 32003, Taiwan
Chia Tai Enterprise Co Ltd, Tao Yuan 32464, TaiwanYuan Ze Univ, Dept Chem Engn & Mat Sci, Tao Yuan 32003, Taiwan
Chin, Chih-Ping
论文数: 引用数:
h-index:
机构:
Wu, Ho-Shing
Wang, Shaw S.
论文数: 0引用数: 0
h-index: 0
机构:
Yuan Ze Univ, Dept Chem Engn & Mat Sci, Tao Yuan 32003, TaiwanYuan Ze Univ, Dept Chem Engn & Mat Sci, Tao Yuan 32003, Taiwan